• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝活检在评估非酒精性脂肪性肝病中的作用。

The role of liver biopsy to assess non-alcoholic fatty liver disease.

作者信息

Kobyliak Nazarii, Abenavoli Ludovico

机构信息

Department of Endocrinology, Bogomolets National Medical University, Kiev, Ukraine, address: 01610, Pushkinska 22a.

出版信息

Rev Recent Clin Trials. 2014;9(3):159-69. doi: 10.2174/1574887109666141216102231.

DOI:10.2174/1574887109666141216102231
PMID:25514908
Abstract

Liver biopsy, since 1883, when were first performed, became the gold standard to confirm the earlier stages of fibrosis and grading of non-alcoholic fatty liver disease (NAFLD) and for distinguishing simple steatosis from non- alcoholic steatohepatitis (NASH). General limitations of liver biopsy are sampling error and inter- and intraobserver variability. Also procedure is invasive and that's why associated with some potential adverse effects and complications which may be minor (pain or vagal reactions, transient hypotension) or major such as visceral perforation, bile peritonitis or significant bleeding. Presence of steatosis, hepatocellular injury in the form of ballooning, lobular inflammation and perisinusoidal fibrosis, usually with a zone 3 distribution are considered to be most important histological features of adult NAFLD which may differ from bariatric surgery or pediatric patients. In addition, grading and staging and current semiquantitative systems for NAFLD assessment are discussed.

摘要

自1883年首次进行肝活检以来,它已成为确认非酒精性脂肪性肝病(NAFLD)纤维化早期阶段和分级以及区分单纯性脂肪变性与非酒精性脂肪性肝炎(NASH)的金标准。肝活检的一般局限性包括抽样误差以及观察者间和观察者内的变异性。此外,该检查具有侵入性,这就是为什么它会伴有一些潜在的不良反应和并发症,这些反应和并发症可能较轻(疼痛或迷走神经反应、短暂性低血压),也可能较严重,如内脏穿孔、胆汁性腹膜炎或严重出血。脂肪变性、气球样变形式的肝细胞损伤、小叶炎症和窦周纤维化的存在,通常呈3区分布,被认为是成人NAFLD最重要的组织学特征,这可能与减肥手术或儿科患者不同。此外,还讨论了NAFLD评估的分级、分期和当前的半定量系统。

相似文献

1
The role of liver biopsy to assess non-alcoholic fatty liver disease.肝活检在评估非酒精性脂肪性肝病中的作用。
Rev Recent Clin Trials. 2014;9(3):159-69. doi: 10.2174/1574887109666141216102231.
2
Histopathology, grading and staging of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的组织病理学、分级与分期
Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25.
3
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
4
Pathology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的病理学。
Liver Int. 2017 Jan;37 Suppl 1:85-89. doi: 10.1111/liv.13301.
5
The Role of Liver Biopsy to Assess Alcoholic Liver Disease.肝活检在评估酒精性肝病中的作用。
Rev Recent Clin Trials. 2016;11(3):175-9. doi: 10.2174/1574887111666160724184103.
6
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
7
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.高通量、基于机器学习的非酒精性脂肪性肝病患者肝活检组织中脂肪变性、炎症、气球样变、纤维化的定量分析。
Clin Gastroenterol Hepatol. 2020 Aug;18(9):2081-2090.e9. doi: 10.1016/j.cgh.2019.12.025. Epub 2019 Dec 27.
8
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.氧化型低密度脂蛋白抗体/高密度脂蛋白胆固醇比值与晚期非酒精性脂肪性肝病瘦患者有关。
J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.
9
Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.经活检证实的非酒精性脂肪性肝病和非酒精性脂肪性肝炎在成年胆结石患者前瞻性队列中的患病率及危险因素
Liver Int. 2015 Aug;35(8):1983-91. doi: 10.1111/liv.12813. Epub 2015 Mar 5.
10
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的组织病理学
Metabolism. 2016 Aug;65(8):1080-6. doi: 10.1016/j.metabol.2015.11.008. Epub 2015 Dec 2.

引用本文的文献

1
S index: a predictor comparable to ultrasound shear wave elastography in assessing liver fibrosis in patients with chronic hepatitis B.S指数:一种在评估慢性乙型肝炎患者肝纤维化方面可与超声剪切波弹性成像相媲美的预测指标。
BMC Med Imaging. 2025 Jul 28;25(1):296. doi: 10.1186/s12880-025-01846-3.
2
Wulingsan Alleviates MAFLD by Activating Autophagy via Regulating the AMPK/mTOR/ULK1 Signaling Pathway.五苓散通过调控 AMPK/mTOR/ULK1 信号通路激活自噬缓解 MAFLD。
Can J Gastroenterol Hepatol. 2024 Jul 13;2024:9777866. doi: 10.1155/2024/9777866. eCollection 2024.
3
Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up.
腰围与大腿围之比作为MAFLD的预测指标:一项为期2年随访的医护人员研究
BMC Gastroenterol. 2024 Apr 24;24(1):144. doi: 10.1186/s12876-024-03229-4.
4
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.超声在炎症性肠病患者中非酒精性脂肪性肝病的流行情况及临床特征:一项真实世界的横断面研究。
Medicina (Kaunas). 2023 Nov 1;59(11):1935. doi: 10.3390/medicina59111935.
5
Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease.膳食多酚与非酒精性脂肪性肝病。
Nutrients. 2021 Feb 3;13(2):494. doi: 10.3390/nu13020494.
6
Safety of liver biopsy at the time of bariatric surgery: an analysis of the MBSAQIP database.在肥胖症手术时进行肝活检的安全性:MBSAQIP 数据库分析。
Surg Endosc. 2022 Jan;36(1):413-421. doi: 10.1007/s00464-021-08297-1. Epub 2021 Jan 22.
7
Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease.荷叶碱治疗非酒精性脂肪性肝病大鼠的作用及机制的非靶向代谢组学分析
Front Pharmacol. 2020 Jun 9;11:858. doi: 10.3389/fphar.2020.00858. eCollection 2020.
8
Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease.奥贝胆酸:非酒精性脂肪性肝病治疗的新时代。
Pharmaceuticals (Basel). 2018 Oct 11;11(4):104. doi: 10.3390/ph11040104.
9
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.血清自分泌运动因子水平与非酒精性脂肪性肝病患者的肝纤维化和气球样变相关。
World J Gastroenterol. 2018 Mar 21;24(11):1239-1249. doi: 10.3748/wjg.v24.i11.1239.
10
Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的多酚类物质治疗
J Transl Int Med. 2017 Sep 30;5(3):144-147. doi: 10.1515/jtim-2017-0027. eCollection 2017 Sep.